HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jens Wagenblast Selected Research

BI 2536

3/2013Antitumoral effect of PLK-1-inhibitor BI2536 in combination with cisplatin and docetaxel in squamous cell carcinoma cell lines of the head and neck.
12/2012Fighting cancer from different signalling pathways: Effects of the proteasome inhibitor Bortezomib in combination with the polo-like-kinase-1-inhibitor BI2536 in SCCHN.
11/2012Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?
7/2012Effects of the Polo-like-kinase-1-inhibitor BI2536 in squamous cell carcinoma cell lines of the head and neck.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jens Wagenblast Research Topics

Disease

19Squamous Cell Carcinoma of Head and Neck
01/2019 - 01/2006
19Neoplasms (Cancer)
01/2019 - 01/2006
9Squamous Cell Carcinoma (Epidermoid Carcinoma)
03/2013 - 03/2007
6Head and Neck Neoplasms (Head and Neck Cancer)
09/2013 - 01/2006
4Multiple Myeloma
03/2009 - 03/2008
3High-Frequency Hearing Loss
10/2011 - 04/2009
2Squamous Cell Neoplasms (Squamous Cell Cancer)
09/2007 - 02/2007
1Pain (Aches)
08/2015
1Deglutition Disorders (Dysphagia)
09/2013
1Exanthema (Rash)
07/2012
1Laryngeal Neoplasms (Laryngeal Cancer)
07/2010
1Weight Loss (Weight Reduction)
07/2009
1Fatigue
07/2009

Drug/Important Bio-Agent (IBA)

8Cisplatin (Platino)FDA LinkGeneric
09/2015 - 01/2006
7Bortezomib (Velcade)FDA Link
12/2012 - 03/2008
6Cetuximab (Erbitux)FDA Link
09/2015 - 07/2008
6Docetaxel (Taxotere)FDA Link
03/2013 - 01/2006
4BI 2536IBA
03/2013 - 07/2012
4Proteasome Endopeptidase Complex (Proteasome)IBA
12/2012 - 03/2008
3Epidermal Growth Factor (EGF)IBA
09/2012 - 03/2008
3Dexamethasone (Maxidex)FDA LinkGeneric
01/2010 - 11/2008
3Antineoplastic Agents (Antineoplastics)IBA
01/2010 - 11/2008
3Pharmaceutical PreparationsIBA
07/2009 - 03/2008
2Proteasome InhibitorsIBA
12/2012 - 03/2008
2Biological ProductsIBA
07/2012 - 11/2008
2GlucocorticoidsIBA
01/2010 - 07/2009
2Fluorouracil (Carac)FDA LinkGeneric
02/2007 - 01/2006
1Adapalene (Differin)FDA LinkGeneric
01/2019
1Nerve Growth Factor Receptor (Nerve Growth Factor Receptor, Low Affinity)IBA
01/2019
1Nerve Growth Factor Receptors (Neurotrophin Receptors)IBA
01/2019
1Proteins (Proteins, Gene)FDA Link
10/2015
1Hyaluronan ReceptorsIBA
10/2015
1Aldehyde Dehydrogenase 1 FamilyIBA
10/2015
1Serotonin (5 Hydroxytryptamine)IBA
09/2012
1Anti-Allergic Agents (Antiallergic Agents)IBA
07/2009
1AntiemeticsIBA
07/2009
1Therapeutic UsesIBA
11/2008
1GadoliniumIBA
05/2008
1ErbB Receptors (EGF Receptor)IBA
03/2008
1Contrast MediaIBA
10/2007
1ferric oxide (iron oxide)IBA
09/2007
1ferumoxtran-10 (ultrasmall superparamagnetic iron oxide)IBA
09/2007
1Dinoprostone (PGE2)FDA Link
03/2007
1Tumor Biomarkers (Tumor Markers)IBA
03/2007
1Indicators and Reagents (Reagents)IBA
03/2007

Therapy/Procedure

8Therapeutics
01/2019 - 03/2009
6Drug Therapy (Chemotherapy)
09/2015 - 01/2006
3Re-Irradiation
09/2015 - 07/2012
2Electrodes (Electrode)
01/2010 - 04/2009
1Cochlear Implantation
10/2011
1Lasers (Laser)
07/2010
1Aftercare (After-Treatment)
03/2007
1Induction Chemotherapy
02/2007
1Neoadjuvant Therapy
02/2007
1Combination Drug Therapy (Combination Chemotherapy)
01/2006